XEMBIFY
Updated 33 days ago
General Counsel 79 T.W. Alexander Drive 4101 Research Commons Research Triangle Park, NC 27709
XEMBIFY® (immune globulin subcutaneous human-klhw) is a 20% immune globulin used in the treatment of primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older. XEMBIFY is for subcutaneous administration only...
Xembify is a proven treatment option for people living with Primary Immunodeficiency Disease. Learn how Xembify can empower your life with PI...
XEMBIFY should not be used if you have had a severe allergic reaction to human immune globulin, or if you have been told by a doctor that you are IgA deficient and have developed antibodies to IgA and hypersensitivity after exposure to a previous plasma product.
Also known as: Grifols